Overall, there was a reclassified tumor type in 42 samples (39 STS, 3 LTS), which were previously classified as astrocytoma, IDH-wildtype and fulfilled molecular criteria of glioblastoma. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).